Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers.

Department of Microbiology and Immunology, University of Rochester Medical Center, NY, USA.
The Pediatric Infectious Disease Journal (Impact Factor: 3.14). 02/1997; 16(1):72-4. DOI: 10.1097/00006454-199701000-00016
Source: PubMed
  • [Show abstract] [Hide abstract]
    ABSTRACT: The immunogenicity of polysaccharides as human vaccines was enhanced by coupling to protein carriers. Conjugation transformed the T cell-independent polysaccharide vaccines of the past to T cell-dependent antigenic vaccines that were much more immunogenic and launched a renaissance in vaccinology. This review discusses the conjugate vaccines for prevention of infections caused by Hemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis. Specifically, the characteristics of the proteins used in the construction of the vaccines including CRM, tetanus toxoid, diphtheria toxoid, Neisseria meningitidis outer membrane complex, and Hemophilus influenzae protein D are discussed. The studies that established differences among and key features of conjugate vaccines including immunologic memory induction, reduction of nasopharyngeal colonization and herd immunity, and antibody avidity and avidity maturation are presented. Studies of dose, schedule, response to boosters, of single protein carriers with single and multiple polysaccharides, of multiple protein carriers with multiple polysaccharides and conjugate vaccines administered concurrently with other vaccines are discussed along with undesirable consequences of conjugate vaccines. The clear benefits of conjugate vaccines in improving the protective responses of the immature immune systems of young infants and the senescent immune systems of the elderly have been made clear and opened the way to development of additional vaccines using this technology for future vaccine products.
    Human Vaccines & Immunotherapeutics 08/2013; 9(12). DOI:10.4161/hv.26109 · 3.64 Impact Factor
  • Source